Julia W. Cohen

526 total citations
14 papers, 393 citations indexed

About

Julia W. Cohen is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Julia W. Cohen has authored 14 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Julia W. Cohen's work include CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Julia W. Cohen is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Julia W. Cohen collaborates with scholars based in United States, Chile and Finland. Julia W. Cohen's co-authors include Natalia Louneva, Steven E. Arnold, Konrad Talbot, David A. Bennett, Liying Han, Robert S. Wilson, John Q. Trojanowski, Hala Kazi, Derek J. Blake and Nirali N. Shah and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Julia W. Cohen

13 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia W. Cohen United States	8	142	101	96	96	37	14	393
Daniel A. Stevens United States	7	430 3.0×	135 1.3×	143 1.5×	146 1.5×	17 0.5×	7	828
Eiichi Katada Japan	14	256 1.8×	25 0.2×	131 1.4×	105 1.1×	10 0.3×	35	514
Yan Tian China	14	380 2.7×	44 0.4×	93 1.0×	111 1.2×	6 0.2×	22	668
Vincent P. Hradil United States	12	160 1.1×	78 0.8×	120 1.3×	113 1.2×	5 0.1×	13	450
Yoshitaka Hasegawa Japan	12	96 0.7×	67 0.7×	78 0.8×	26 0.3×	4 0.1×	28	469
Marine Christin France	5	223 1.6×	19 0.2×	101 1.1×	179 1.9×	9 0.2×	5	386
Akito Nakao Japan	11	140 1.0×	34 0.3×	112 1.2×	42 0.4×	3 0.1×	26	406
Bo‐Ran Choi United States	8	176 1.2×	23 0.2×	73 0.8×	168 1.8×	9 0.2×	16	478
Kanta Yanagida Japan	14	421 3.0×	57 0.6×	121 1.3×	282 2.9×	9 0.2×	28	762

Countries citing papers authored by Julia W. Cohen

Since Specialization

Citations

This map shows the geographic impact of Julia W. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia W. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia W. Cohen more than expected).

Fields of papers citing papers by Julia W. Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia W. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia W. Cohen. The network helps show where Julia W. Cohen may publish in the future.

Co-authorship network of co-authors of Julia W. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Julia W. Cohen. A scholar is included among the top collaborators of Julia W. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia W. Cohen. Julia W. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Khanyile, Richard, Graham Cohen, Chloe Walton, et al.. (2025). Abstract CT035: Pharmacokinetics (PK), safety, and tolerability of pembrolizumab with berahyaluronidase alfa administered subcutaneously Q3W in participants with advanced melanoma. Cancer Research. 85(8_Supplement_2). CT035–CT035. 1 indexed citations

Tolcher, Anthony W., Drew Rasco, Melissa L. Johnson, et al.. (2024). Safety and preliminary efficacy of EIK1001 in combination with pembrolizumab in participants with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2521–2521. 2 indexed citations

Santos, João M., Matthew S. Block, Johanna Mäenpää, et al.. (2024). PROTA: A phase I clinical trial combining an oncolytic adenovirus encoding for TNFa and IL-2 with pembrolizumab for the treatment of platinum-resistant or -refractory ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5562–5562.

Daud, Adil, Costantine Albany, Vamsidhar Velcheti, et al.. (2023). First-in-human, phase 1a dose finding of LVGN6051 CD137/4-1BB agonistic antibody with or without pembrolizumab in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2525–2525. 2 indexed citations

Fu, Siqing, Wael A. Harb, Sapna P. Patel, et al.. (2021). Early safety and efficacy from a phase I open-label clinical trial of CD137(4-1BB) agonistic antibody LVGN6051 as monotherapy and in combination with pembrolizumab.. Journal of Clinical Oncology. 39(15_suppl). 2521–2521. 7 indexed citations

Cohen, Julia W., et al.. (2020). A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies. The Oncologist. 25(6). 532–540. 11 indexed citations

Shalabi, Haneen, Vandana Sachdev, Julia W. Cohen, et al.. (2020). Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies. Journal for ImmunoTherapy of Cancer. 8(2). e001159–e001159. 78 indexed citations

Cohen, Julia W., Brigitte C. Widemann, Joanne Derdak, et al.. (2019). Cediranib phase‐II study in children with metastatic alveolar soft‐part sarcoma (ASPS). Pediatric Blood & Cancer. 66(12). e27987–e27987. 11 indexed citations

Glod, John, Julia W. Cohen, Brigitte C. Widemann, et al.. (2018). Cediranib phase II study in children with metastatic alveolar soft part sarcoma (ASPS).. Journal of Clinical Oncology. 36(15_suppl). 10540–10540. 2 indexed citations

10.

Cohen, Julia W. & Andrew W. Walter. (2015). Hypothalamic Glioma in a Patient With Sturge-Weber Syndrome. Journal of Pediatric Hematology/Oncology. 38(1). e10–e12. 4 indexed citations

11.

Talbot, Konrad, Natalia Louneva, Julia W. Cohen, et al.. (2011). Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location. PLoS ONE. 6(3). e16886–e16886. 62 indexed citations

12.

Cohen, Julia W., Natalia Louneva, Liying Han, et al.. (2010). Chronic corticosterone exposure alters postsynaptic protein levels of PSD‐95, NR1, and synaptopodin in the mouse brain. Synapse. 65(8). 763–770. 30 indexed citations

13.

Louneva, Natalia, Julia W. Cohen, Liying Han, et al.. (2008). Caspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease. American Journal Of Pathology. 173(5). 1488–1495. 164 indexed citations

14.

Russell, William O., Julia W. Cohen, J H Edmonson, et al.. (1981). Staging system for soft tissue sarcoma.. PubMed. 8(2). 156–9. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact